Biomarker-directed Targeted Therapy in Colorectal Cancer.
about
A polymorphism rs4705341 in the flanking region of miR-143/145 predicts risk and prognosis of colorectal cancer.KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
P2860
Biomarker-directed Targeted Therapy in Colorectal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biomarker-directed Targeted Therapy in Colorectal Cancer.
@en
type
label
Biomarker-directed Targeted Therapy in Colorectal Cancer.
@en
prefLabel
Biomarker-directed Targeted Therapy in Colorectal Cancer.
@en
P2860
P1476
Biomarker-directed Targeted Therapy in Colorectal Cancer.
@en
P2093
John M Carethers
P2860
P577
2015-06-01T00:00:00Z